Large-scale testing (Phase 3)Looking for participantsNCT04221035
What this trial is testing
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Who this might be right for
High-Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris 800